IT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB)
ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB) / A., P., A., P., F., L., S., P., Paolucci, P., R., M., G., P.. - In: BONE MARROW TRANSPLANTATION. - ISSN 0268-3369. - STAMPA. - UNICO:(1996), pp. 349, S 76-349, S 76. (22th ANNUAL MEETING of the EBMT Vienna 3-7 March 1996).
ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB)
PAOLUCCI, Paolo;
1996
Abstract
IT IS DESCRIBED THE ROLE OF AN ADOPTIVE IMMUNOTHERAPY WITH RECOMBINANT IL-2 AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION (ABMT) FOR HIGH RISK NEUROBLASTOMA (HR-NB)Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




